Fresenius Medical Care AG
FME: XETR (DEU)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| m@ | LOCK|RCw< | LOCK|%@?zK<D |
Fresenius Medical Care Earnings: Mild Profit Growth and Maintained Outlook Cut Into Shares
On May 5, Fresenius reported first-quarter results that contained a 6% revenue decline (4% growth organically after divestitures), 2% adjusted operating profit growth, and 8% adjusted EPS growth including share repurchases. The firm maintained its 2026 outlook, including roughly flat profits.
